Condition 101 About Peripheral T-Cell Lymphoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Local Doctors For Peripheral T-Cell Lymphoma

View All Doctors

Latest Advances On Peripheral T-Cell Lymphoma

  • Condition: Peripheral T-Cell Lymphomas
  • Journal: Cell transplantation
  • Treatment Used: Myeloablative Haploidentical Transplant
  • Number of Patients: 52
  • Published —
This study investigated the use of myeloablative haploidentical transplant as an alternative to matched sibling transplant for peripheral T-cell lymphomas.
  • Condition: Relapsed Primary Gastric Peripheral T-Cell Lymphoma
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Total Gastrectomy followed by Add-on Chemotherapy
  • Number of Patients: 1
  • Published —
The study researched the safety and effectiveness of total gastrectomy followed by adjuvant chemotherapy for relapsed primary gastric peripheral T-cell lymphoma.
View All Latest Advances

Clinical Trials For Peripheral T-Cell Lymphoma

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 170
  • Start Date: June 2021
A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 176
  • Start Date: May 31, 2021
Single-arm, Phase 2 Study of Valemetostat Tosylate Monotherapy in Subjects With Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
View All Clinical Trials